Journal of Craniovertebral Junction and Spine : Table of Contents

Users Online: 154

Article Cited by others

ORIGINAL ARTICLE

Use of recombinant human bone morphogenetic protein-2 as an adjunct for instrumented posterior arthrodesis in the occipital cervical region: An analysis of safety, efficacy, and dosing

Hamilton D Kojo, Smith Justin S, Reames Davis L, Williams Brian J, Shaffrey Christopher I

Year : 2010| Volume: 1| Issue : 2 | Page no: 107-112

This article has been cited by

1	Letter: Reconsidering Bone Morphogenetic Protein in the Cervical Spine: Selective Use for Managing Type II Odontoid Fractures in the Elderly

	Francis J Jareczek, Kingsley O Abode-Iyamah, Efrem M Cox, Nader S Dahdaleh, Patrick W Hitchon, Matthew A Howard

	Operative Neurosurgery. 2017; 13(6): E39

	[Pubmed] [Google Scholar] [DOI]

2	Cancer After Spinal Fusion

	Shivanand P. Lad,Jacob H. Bagley,Isaac O. Karikari,Ranjith Babu,Beatrice Ugiliweneza,Maiying Kong,Robert E. Isaacs,Carlos A. Bagley,Oren N. Gottfried,Chirag G. Patil,Maxwell Boakye

	Neurosurgery. 2013; 73(3): 440

	[Pubmed] [Google Scholar] [DOI]

3	The concern on clinical use of recombinant human bone morphogenetic protein-2

	Wiwanitkit, V.

	Journal of Craniovertebral Junction and Spine. 2011; 2(2): 102-103

	[Pubmed] [Google Scholar]